Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Cancer Biology & Therapy|April 12, 2007
LS14 cells: a model for chemoresistance in liposarcomaElizabeth W LaPensee, Shamantha P Reddy, Eric R Hugo, et al.
Interactive Cardiovascular and Thoracic Surgery|August 3, 2007
NT-proBNP in cardiac surgery: a new tool for the management of our patients?Guillermo Reyes, Gloria Forés, R Hugo Rodríguez-Abella, et al.
Endocrinology|July 1, 2006
The prolactin-deficient mouse has an unaltered metabolic phenotypeChristopher R LaPensee, Nelson D Horseman, Patrick Tso, et al.
Environmental Health Perspectives|December 17, 2008
Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytesEric R Hugo, Terry D Brandebourg, Jessica G Woo, et al.
Plos One|October 4, 2011
Dopamine receptors in human adipocytes: expression and functionsDana C Borcherding, Eric R Hugo, Gila Idelman, et al.
Endocrinology|October 1, 2005
LS14: a novel human adipocyte cell line that produces prolactinEric R Hugo, Terry D Brandebourg, Clay E S Comstock, et al.
Analytical Biochemistry|June 12, 2001
A homogeneous fluorometric assay for measuring cell adhesion to immobilized ligand using V-well microtiter platesM Weetall, R Hugo, C Friedman, et al.
Oncogene|October 20, 2015
Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancerD C Borcherding, W Tong, E R Hugo, et al.
Molecular Immunology|October 31, 2001
Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxinsJ M Hexham, D Dudas, R Hugo, et al.
Cancers|June 2, 2021
Suppression of Breast Cancer by Small Molecules That Block the Prolactin ReceptorDana C Borcherding, Eric R Hugo, Sejal R Fox, et al.
Pageof 6